Philip Morris International (NYSE:PM) Issues Earnings Results, Beats Estimates By $0.13 EPS

Philip Morris International (NYSE:PM) posted its earnings results on Wednesday. The company reported $1.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.83 by $0.13, FiscalAI reports. The company had revenue of $10.15 billion during the quarter, compared to the consensus estimate of $9.95 billion. Philip Morris International had a net margin of 12.09% and a negative return on equity of 130.95%. The firm’s quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the firm posted $1.69 earnings per share. Philip Morris International updated its FY 2026 guidance to 8.360-8.510 EPS and its Q2 2026 guidance to 2.020-2.070 EPS.

Philip Morris International Stock Performance

Shares of PM stock traded up $9.72 on Wednesday, reaching $162.97. 1,626,176 shares of the company were exchanged, compared to its average volume of 5,172,250. The company has a market cap of $253.99 billion, a price-to-earnings ratio of 22.37, a P/E/G ratio of 1.92 and a beta of 0.43. The business has a 50-day moving average price of $170.57 and a 200 day moving average price of $163.81. Philip Morris International has a 1 year low of $142.11 and a 1 year high of $191.30.

Philip Morris International Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, April 13th. Stockholders of record on Thursday, March 19th were paid a dividend of $1.47 per share. The ex-dividend date of this dividend was Thursday, March 19th. This represents a $5.88 dividend on an annualized basis and a dividend yield of 3.6%. Philip Morris International’s payout ratio is currently 80.88%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on PM shares. Barclays restated an “overweight” rating and set a $205.00 target price on shares of Philip Morris International in a research report on Monday, February 23rd. Needham & Company LLC decreased their target price on shares of Philip Morris International from $205.00 to $200.00 and set a “buy” rating for the company in a research report on Monday, April 13th. Morgan Stanley decreased their target price on shares of Philip Morris International from $205.00 to $190.00 and set an “overweight” rating for the company in a research report on Friday. Stifel Nicolaus decreased their target price on shares of Philip Morris International from $200.00 to $195.00 and set a “buy” rating for the company in a research report on Friday, April 10th. Finally, Jefferies Financial Group cut shares of Philip Morris International from a “buy” rating to a “hold” rating and cut their price objective for the company from $220.00 to $180.00 in a report on Tuesday, January 20th. Ten investment analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $192.56.

Key Headlines Impacting Philip Morris International

Here are the key news stories impacting Philip Morris International this week:

• Positive Sentiment: Q1 results topped expectations: adjusted EPS of $1.96 beat consensus and revenue of $10.15B exceeded estimates, signaling resilient demand. Investing.com: Philip Morris beats Q1 estimates
• Positive Sentiment: Smoke?free product strength: management highlighted continued growth in IQOS and other smoke?free offerings, supporting longer?term revenue mix improvement. WSJ: Sales rise on smoke-free business growth
• Positive Sentiment: Regulatory win for IQOS: the product retains FDA modified?risk authorization, preserving a strategic competitive advantage in reduced?risk products. Zacks: IQOS retains FDA modified-risk authorization
• Neutral Sentiment: FY?2026 EPS guidance roughly in line with street: company issued a 8.360–8.510 EPS range that tracks consensus (~8.37), so full?year outlook is not a major surprise. FinancialPost: Q1 results and FY update
• Negative Sentiment: Near?term EPS guidance missed Q2 consensus: management set Q2 EPS at 2.020–2.070 vs. consensus ~2.12, which markets view as a near?term earnings shortfall. Company press release: Q1 results & guidance
• Negative Sentiment: Company cut its annual profit forecast amid competitive pressure and regulatory uncertainty (notably around Zyn nicotine pouches), which raises medium?term margin concerns. Reuters: Philip Morris cuts annual profit forecast

Insider Transactions at Philip Morris International

In other news, CFO Emmanuel Babeau sold 33,800 shares of the business’s stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $181.61, for a total transaction of $6,138,418.00. Following the completion of the sale, the chief financial officer owned 164,463 shares of the company’s stock, valued at $29,868,125.43. The trade was a 17.05% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Jacek Olczak sold 80,000 shares of the business’s stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $182.18, for a total transaction of $14,574,400.00. Following the sale, the chief executive officer directly owned 632,344 shares of the company’s stock, valued at $115,200,429.92. This represents a 11.23% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. 0.13% of the stock is owned by insiders.

Institutional Trading of Philip Morris International

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Bank of America Corp DE increased its stake in shares of Philip Morris International by 4.0% during the fourth quarter. Bank of America Corp DE now owns 15,383,248 shares of the company’s stock worth $2,467,473,000 after purchasing an additional 594,867 shares in the last quarter. Northern Trust Corp boosted its position in Philip Morris International by 2.8% during the third quarter. Northern Trust Corp now owns 14,701,879 shares of the company’s stock worth $2,384,645,000 after acquiring an additional 401,381 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in Philip Morris International by 12.5% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 14,161,027 shares of the company’s stock worth $2,271,430,000 after acquiring an additional 1,569,685 shares during the last quarter. Charles Schwab Investment Management Inc. boosted its position in Philip Morris International by 1.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 13,338,069 shares of the company’s stock worth $2,139,869,000 after acquiring an additional 191,257 shares during the last quarter. Finally, Boston Partners boosted its position in Philip Morris International by 12.7% during the third quarter. Boston Partners now owns 7,019,625 shares of the company’s stock worth $1,136,402,000 after acquiring an additional 791,681 shares during the last quarter. Hedge funds and other institutional investors own 78.63% of the company’s stock.

Philip Morris International Company Profile

Philip Morris International Inc (NYSE: PM) is a global tobacco company that manufactures and sells cigarettes, other nicotine-containing products and a growing portfolio of smoke-free alternatives for adult smokers. The firm traces its corporate roots to the 19th century Philip Morris enterprise and was established as an independent, publicly traded company following a 2008 separation from what is now Altria. Since the spin-off, the company has focused on serving international markets outside the United States.

PMI’s product mix includes traditional combustible cigarettes as well as smoke-free offerings such as heated tobacco systems and other reduced-risk products.